Company intelligence / Profile preview

Sleepiz

Zurich, Zurich, Switzerlandsleepiz.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

The company’s contactless device for home use has been approved as a medical device in Europe and listed with the FDA for the US. It enables accurate measurement of respiration and heart rate to diagnose conditions like sleep apnea. Clinical validation claims up to 99% accuracy compared to traditional methods. The technology has been deployed in pilot studies, clinical trials, and commercial screening programs.

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceNon-pharmacological therapy (contactless monitoring)
Industry: Physiological Monitoring

Partnerships

Clario (for clinical trial data collection features)Lunge Zurich association (partner since summer of 2021; public health collaboration for lung/sleep disorders screening)

Beyond the preview

Go deeper on Sleepiz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sleepiz.

Explore the full profile